UK markets close in 27 minutes

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
139.68+2.15 (+1.56%)
As of 11:03AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts18171818
Avg. Estimate1.011.184.776.41
Low estimate0.180.893.824.58
High estimate1.771.675.728.58
Year ago EPS-0.790.952.474.77
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts24222626
Avg. Estimate511.97M545.66M2.21B2.58B
Low estimate491.5M529M2.14B2.26B
High estimate528M581M2.36B3.78B
Year ago sales409.26M447.31M1.89B2.21B
Sales growth (year/est)25.10%22.00%17.40%16.50%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS0.130.780.971.14
Actual EPS-0.790.950.821.44
Difference-0.920.17-0.150.3
Surprise %-707.70%21.80%-15.50%26.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate1.011.184.776.41
7 days ago1.011.184.786.52
30 days ago11.194.86.29
60 days ago11.194.796.3
90 days ago1.061.164.76.4
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days2222
Up last 30 days6557
Down last 7 daysN/AN/AN/AN/A
Down last 30 days4334
Growth estimatesNBIXIndustrySector(s)S&P 500
Current qtr.227.80%N/AN/AN/A
Next qtr.24.20%N/AN/AN/A
Current year93.10%N/AN/AN/A
Next year34.40%N/AN/AN/A
Next 5 years (per annum)18.00%N/AN/AN/A
Past 5 years (per annum)22.55%N/AN/AN/A